Masahiro Toda (Ryota Tamura)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Traumatic Brain Injury

Inflammatory Response

Vascular Endothelial Growth Factor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Medicines (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Toda, Yoshiharu Yamanobe, Masato Fujioka, Yukina Morimoto, Mariko Fukumura, Masato Nakaya, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Tetsuro Hikichi, Shinobu Noji, Naoki Oishi, Hiroyuki Ozawa, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida, Masahiro Toda
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Katsuhiro Kawaai, Yumiko Oishi, Yukiko Kuroda, Masahiro Toda, Masahiro Toda, Koichi Matsuo
Chordoma cells possess bone-dissolving activity at the bone invasion front. Cellular oncology (Dordrecht) (2024)
Masahiro Toda, Yoshiharu Yamanobe, Masato Fujioka, Yukina Morimoto, Mariko Fukumura, Masato Nakaya, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Tetsuro Hikichi, Shinobu Noji, Naoki Oishi, Hiroyuki Ozawa, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida, Masahiro Toda
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Ryota Tamura, Yoshiharu Yamanobe, Masato Fujioka, Yukina Morimoto, Mariko Fukumura, Masato Nakaya, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Tetsuro Hikichi, Shinobu Noji, Naoki Oishi, Hiroyuki Ozawa, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida, Masahiro Toda
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Masahiro Toda
Drug Repositioning for Refractory Benign Tumors of the Central Nervous System. International journal of molecular sciences 24 (16) (2023)
Ryotaro Imai, Masahiro Toda, Masahiro Yo, Mizuto Sato, Mariko Fukumura, Kento Takahara, Yoshitaka Kase, Hideyuki Okano, Masahiro Toda
Neuroprotective effects of genome-edited human iPS cell-derived neural stem/progenitor cells on traumatic brain injury. Stem cells (Dayton, Ohio) (2023)
Kosuke Karatsu, Masahiro Toda, Tsubasa Miyauchi, Junki Sogano, Utaro Hino, Takashi Iwama, Masahiro Toda
Clinical Effectiveness of Mirogabalin Besylate for Trigeminal Neuropathy after Skull Base Surgery: Illustrative Cases. Medicines (Basel, Switzerland) 10 (8) (2023)
Masahiro Toda, Yuki Kuranari, Hideki Orikasa, Makoto Katayama
Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report. Medicines (Basel, Switzerland) 9 (4) (2022)
Masahiro Toda, Masahiro Toda
A Critical Overview of Targeted Therapies for Vestibular Schwannoma. International journal of molecular sciences 23 (10) (2022)
Masahiro Toda, Hiroyuki Miyoshi, Kent Imaizumi, Masahiro Yo, Yoshitaka Kase, Tsukika Sato, Mizuto Sato, Yukina Morimoto, Oltea Sampetrean, Jun Kohyama, Munehisa Shinozaki, Atsushi Miyawaki, Kazunari Yoshida, Hideyuki Saya, Hideyuki Okano, Masahiro Toda
Gene therapy using genome-edited iPS cells for targeting malignant glioma. Bioengineering & translational medicine 8 (5) (2022)
Taichi Sayanagi, Yumiko Ohishi, Makoto Katayama, Masahiro Toda
Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer: A Rare Phenomenon? Medicines (Basel, Switzerland) 9 (7) (2022)
Kento Takahara, Makoto Katayama, Masahiro Toda
Prolonged Survival and Restored Useful Life by Early Induction of Intrathecal Chemotherapy in a Patient with Leptomeningeal Carcinomatosis from Ovarian Cancer. Brain sciences 12 (6) (2022)
Masahiro Toda
Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis. International journal of molecular sciences 22 (11) (2021)
Yumiko Oishi, Masahiro Toda, Kazunari Yoshida, Masahiro Toda
Histopathological Investigation of Dura-like Membrane in Vestibular Schwannomas. Brain sciences 11 (12) (2021)
Masahiro Toda, Masato Fujioka, Yukina Morimoto, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Tetsuro Hikichi, Shinobu Noji, Naoki Oishi, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida, Masahiro Toda
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature communications 11 (1) (2020)
Masahiro Toda, Masato Fujioka, Yukina Morimoto, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Tetsuro Hikichi, Shinobu Noji, Naoki Oishi, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida, Masahiro Toda
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature communications 10 (1) (2019)